dsm-firmenich figures: five-years summary

Reporting period

The five-years summary includes information that is presented in accordance with IFRS, which includes Firmenich from the merger date onwards. All figures are including discontinued operations unless stated otherwise, see also Note 3 Change in the scope of the consolidation.

Balance sheet

x € million

 

2023

 

2022

 

2021

 

2020

 

2019

Assets

 

 

 

 

 

 

 

 

 

 

Goodwill and intangible assets

 

18,738

 

5,147

 

5,309

 

4,440

 

3,515

Property, plant and equipment

 

5,549

 

3,576

 

3,964

 

3,775

 

4,040

Deferred tax assets

 

228

 

95

 

203

 

240

 

217

Share in associates and joint ventures

 

130

 

61

 

64

 

93

 

155

Derivatives

 

46

 

82

 

48

 

61

 

27

Other financial assets

 

735

 

314

 

302

 

317

 

265

Non-current assets

 

25,426

 

9,275

 

9,890

 

8,926

 

8,219

 

 

 

 

 

 

 

 

 

 

 

Inventories

 

3,390

 

2,339

 

2,297

 

1,879

 

2,019

Current receivables

 

2,843

 

1,622

 

1,697

 

1,483

 

1,698

Derivatives

 

42

 

42

 

30

 

48

 

19

Current investments

 

107

 

125

 

489

 

43

 

688

Cash and cash equivalents

 

2,456

 

2,755

 

1,561

 

871

 

800

Assets held for sale

 

6

 

1,245

 

56

 

1,096

 

-

Current assets

 

8,844

 

8,128

 

6,130

 

5,420

 

5,224

Total assets

 

34,270

 

17,403

 

16,020

 

14,346

 

13,443

 

 

 

 

 

 

 

 

 

 

 

Equity and liabilities

 

 

 

 

 

 

 

 

 

 

Shareholders’ equity

 

22,908

 

10,743

 

9,318

 

7,399

 

7,731

Non-controlling interests

 

162

 

102

 

79

 

88

 

104

Equity

 

23,070

 

10,845

 

9,397

 

7,487

 

7,835

 

 

 

 

 

 

 

 

 

 

 

Deferred tax liabilities

 

1,751

 

476

 

490

 

431

 

296

Employee benefit liabilities

 

520

 

287

 

323

 

414

 

413

Provisions

 

142

 

50

 

96

 

123

 

120

Borrowings

 

4,114

 

2,978

 

2,995

 

3,484

 

2,464

Derivatives

 

8

 

4

 

9

 

1

 

7

Other non-current liabilities

 

146

 

205

 

280

 

163

 

145

Non-current liabilities

 

6,681

 

4,000

 

4,193

 

4,616

 

3,445

 

 

 

 

 

 

 

 

 

 

 

Employee benefits liabilities

 

49

 

5

 

21

 

42

 

43

Provisions

 

34

 

45

 

68

 

61

 

48

Borrowings

 

716

 

86

 

103

 

102

 

189

Derivatives

 

28

 

23

 

40

 

13

 

18

Current liabilities

 

3,684

 

1,969

 

2,188

 

1,771

 

1,865

Liabilities held for sale

 

8

 

430

 

10

 

254

 

-

Current liabilities

 

4,519

 

2,558

 

2,430

 

2,243

 

2,163

Total equity and liabilities

 

34,270

 

17,403

 

16,020

 

14,346

 

13,443

Income statement

x € million

 

2023

 

2022

 

2021

 

2020

 

2019

Net sales

 

11,015

 

10,480

 

9,468

 

9,038

 

9,010

Net sales from continuing operations

 

10,627

 

8,390

 

7,269

 

-

 

-

 

 

 

 

 

 

 

 

 

 

 

Adjusted EBITDA1

 

1,441

 

1,725

 

1,842

 

1,650

 

1,684

EBITDA

 

3,637

 

2,646

 

2,370

 

1,476

 

1,586

 

 

 

 

 

 

 

 

 

 

 

Adjusted operating profit (EBIT)1

 

428

 

1,071

 

1,167

 

1,011

 

1,075

Operating profit (EBIT)

 

2,330

 

1,994

 

1,689

 

736

 

954

Operating profit (EBIT) from continuing operations

 

(497)

 

682

 

711

 

-

 

-

Financial income and expense

 

(151)

 

(94)

 

(106)

 

(67)

 

(92)

Income tax expense

 

(19)

 

(190)

 

(245)

 

(129)

 

(152)

Share of the profit of associates and joint ventures

 

(7)

 

5

 

342

 

(32)

 

54

Net profit for the year

 

2,153

 

1,715

 

1,680

 

508

 

764

 

 

 

 

 

 

 

 

 

 

 

Net profit attributable to non-controlling interests

 

16

 

15

 

4

 

2

 

6

Net profit available to equity holders of the parent company

 

2,137

 

1,700

 

1,676

 

506

 

758

 

 

 

 

 

 

 

 

 

 

 

Dividend on Cumulative Preference Shares

 

(6)

 

(6)

 

(6)

 

(7)

 

(8)

Net profit available to holders of ordinary shares

 

2,131

 

1,694

 

1,670

 

499

 

750

 

 

 

 

 

 

 

 

 

 

 

Key figures and financial ratios

 

 

 

 

 

 

 

 

 

 

Capital employed

 

26,766

 

11,473

 

11,019

 

10,557

 

9,311

 

 

 

 

 

 

 

 

 

 

 

Capital expenditure:

 

 

 

 

 

 

 

 

 

 

- Intangible assets and Property, plant and equipment

 

700

 

636

 

614

 

622

 

623

- Acquisitions

 

14,569

 

77

 

754

 

1,579

 

585

Disposals

 

3,559

 

1,413

 

1,941

 

46

 

44

Depreciation, amortization and impairments

 

1,307

 

652

 

681

 

740

 

632

Net debt

 

(2,215)

 

(87)

 

(1,019)

 

(2,577)

 

(1,144)

Dividend

 

582

 

167

 

438

 

420

 

425

 

 

 

 

 

 

 

 

 

 

 

Workforce at 31 December, headcount

 

29,301

 

20,682

 

21,358

 

23,127

 

22,174

 

 

 

 

 

 

 

 

 

 

 

Financial ratios1

 

 

 

 

 

 

 

 

 

 

Current assets/current liabilities

 

1.96

 

3.15

 

2.52

 

2.42

 

2.42

Equity/total assets

 

0.67

 

0.62

 

0.59

 

0.52

 

0.58

Gearing (net debt/equity plus net debt) in %

 

8.8%

 

0.8%

 

9.7%

 

26.0%

 

13.0%

Adjusted EBITDA/net sales in %

 

13.1%

 

16.5%

 

19.5%

 

18.3%

 

18.7%

Adjusted EBITDA/financial income and expense

 

12.3

 

20.1

 

17.4

 

24.6

 

18.3

1

In presenting and discussing DSM’s financial position, operating results and cash flows, DSM uses certain Alternative performance measures (APMs) not defined by IFRS. These APMs are used because they are an important measure of DSM’s business development and DSM’s management performance. A full reconciliation of IFRS performance measures to the APMs is given in Note 2 Alternative performance measures.

Topic filter

Results